Gilead Sciences and LEO Pharma have announced a strategic partnership to accelerate the development and commercialization of LEO Pharma’s small molecule oral STAT6 (signal transducer...
Newron Pharmaceuticals, a biopharmaceutical company focused on the development of novel therapies for diseases of the central and peripheral nervous system, and Myung In...
Er-Kim, an international company specializing in the commercialization of novel therapies for pharmaceutical and biopharmaceutical companies, has signed a distribution agreement with the MEDICE...